TWO of the world's biggest drug firms are stockpiling medicines in case of supply disruptions after Brexit, according to BBC and Wall Street Journal reports.
France's Sanofi is increasing its stocks by a month to give it a 14 week supply of medicines while Switzerland's Novartis said it was also preparing for the possibility of a no-deal Brexit.
Sanofi, which makes insulin, said it is worried about any transport delays following Brexit, as most of its supplies have to cross the English Channel.
Earlier in Jul the UK NHS said it was preparing to stockpile drugs as well, in case of a "no deal" Brexit.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 18
